| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 498,093 | 326,110 | 407,948 | 627,466 | | Cost of Revenue | 346,305 | 248,288 | 305,864 | 439,970 | | | Gross Profit | 151,788 | 77,822 | 102,084 | 187,496 | | | Operating Expenses | | Research Development | 31,825 | 31,360 | 29,744 | 32,401 | | Selling General and Administrative | 92,574 | 80,119 | 95,002 | 112,319 | | Non Recurring | 45 | 1,449 | 20,547 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 27,344 | (35,106) | (43,209) | 42,776 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,032) | 1,396 | 1,670 | 10,324 | | Earnings Before Interest And Taxes | 26,543 | (33,710) | (41,539) | 53,100 | | Interest Expense | (2) | 2 | (121) | 11 | | Income Before Tax | 26,545 | (33,712) | (41,418) | 53,089 | | Income Tax Expense | 5,802 | 3,653 | (6,340) | 12,596 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 20,743 | (37,365) | (35,078) | 40,493 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 20,743 | (37,365) | (35,078) | 40,493 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $20,743 | ($37,365) | ($35,078) | $40,493 |
|
0.51% Nasdaq 
Income Statement
